Osem Fluidics simplifies the process of making nanoparticle drug delivery systems, such as the lipid nanoparticles used for COVID-19 vaccines. We provide single-use lab consumables for pre-clinical R&D, accelerating formulation screening 720x faster at 15% of current costs. We bring scientists simple-to-use solutions for nanosynthesis to catalyze innovation in nanomedicine, ultimately leading to better therapeutic outcomes, sooner.